IP Verse

Crastalline Hydrobromide Salt Of 5-Meo-Dmt

Patent No. EP4313945 (titled "Crastalline Hydrobromide Salt Of 5-Meo-Dmt") was filed by GH Research Ireland on Mar 27, 2023. The application was issued on Mar 13, 2024.

Patent Summary

5-MeO-DMT hydrobromide, a crystalline acid addition salt of 5-MeO-DMT, exhibiting improved formulation characteristics. The salt has enhanced flow properties, stability, and solubility compared to conventional 5-MeO-DMT forms. It is particularly suitable for buccal or sublingual administration routes, offering a stable and pure salt form that maintains its pharmacological activity.

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SCORPIODec 4, 2024SAGITTARIUS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4313945

GH RESEARCH IRELAND
Application Number
EP23717046A
Filing Date
Mar 27, 2023
Status
Granted And Under Opposition
Feb 9, 2024
Publication Date
Mar 13, 2024
External Links
Slate, Register , Google Patents